（文章来源：证券日报） 证券日报网讯 1月19日，新里程在互动平台回答投资者提问时表示，截至2026年1月10日收盘，公司股 东人数为70366户。 ...

Core Viewpoint - The medical services sector experienced a decline of 1.45% on January 19, with Chengdu Xian Dao leading the drop. The Shanghai Composite Index rose by 0.29%, while the Shenzhen Component Index increased by 0.09% [1]. Group 1: Market Performance - The medical services sector saw a significant outflow of 1.45%, with Chengdu Xian Dao's stock price falling by 6.82% to 32.80 [2]. - Major stocks in the medical services sector included New Mileage, which rose by 9.83% to 2.57, and ST Biological, which increased by 5.06% to 8.93 [1][2]. - The total net outflow of main funds in the medical services sector was 1.983 billion, while retail investors saw a net inflow of 1.942 billion [2][3]. Group 2: Individual Stock Performance - New Mileage had a closing price of 2.57 with a trading volume of 3.1192 million shares, resulting in a transaction amount of 778 million [1]. - Chengdu Xian Dao, despite leading the decline, had a trading volume of 292,200 shares and a transaction amount of 976 million [2]. - The stock performance varied significantly, with some stocks like ST Biological and Huazhong Medical showing positive movements, while others like Chengdu Xian Dao and Meinian Health faced notable declines [2][3].

Market Overview - The Shanghai Composite Index closed at 4114.00 points, above the annual line, with a change of 0.29% [1] - The total trading volume of A-shares reached 27,322.16 million yuan [1] Stocks Breaking Annual Line - A total of 129 A-shares have surpassed the annual line today [1] - Notable stocks with significant deviation rates include: - Xinlicheng (8.92%) - Junzheng Group (8.59%) - Tiandi Online (7.60%) [1] Stock Performance Details - The following stocks showed notable performance: - Xinlicheng: Today's change of 9.83%, turnover rate of 9.53%, latest price at 2.57 yuan [1] - Junzheng Group: Today's change of 8.68%, turnover rate of 5.01%, latest price at 5.76 yuan [1] - Tiandi Online: Today's change of 9.99%, turnover rate of 7.71%, latest price at 20.26 yuan [1] - Other stocks with smaller deviation rates include: - Hemai Co., Ltd. - Wukuang Capital - Huadian Liaoning Energy [1]

Group 1 - The stock of Xinli Cheng has experienced a significant increase, with three limit-up days within five trading days, resulting in a cumulative increase of 13.22% and a turnover rate of 49.84% [2] - As of 10:09, the stock's trading volume reached 270 million shares, with a transaction amount of 669 million yuan, and a turnover rate of 8.24% [2] - The total market capitalization of A-shares is currently 8.706 billion yuan, with a circulating market value of 8.409 billion yuan [2] Group 2 - The latest margin trading balance for the stock is 357 million yuan, with a financing balance of 355 million yuan, which decreased by 60.94 million yuan compared to the previous trading day, reflecting a 14.64% decline [2] - Over the past five days, the margin trading balance has increased by 3.09 million yuan, showing a growth of 0.88% [2] - The stock has appeared on the Dragon and Tiger list twice due to a cumulative deviation in price of 20% over three consecutive trading days and a daily volatility of 15% [2] Group 3 - The net selling by the Shenzhen Stock Connect totaled 15.861 million yuan, while the total net selling by brokerage seats reached 59.4185 million yuan [2] - Recent trading performance shows fluctuations, with notable declines on January 15 and January 16, where the stock dropped by 5.45% and 10.00% respectively [2] - The main capital inflow and outflow data indicate significant negative net inflows on January 15 and January 16, with net outflows of 44.120 million yuan and 106.2079 million yuan respectively [2]

Market Overview - As of January 15, the Shanghai Composite Index closed at 4112.60 points, with a decline of 0.33%. The Shenzhen Component Index closed at 14306.73 points, increasing by 0.41%. The ChiNext Index closed at 3367.92 points, rising by 0.56% [1] Trading Volume Analysis - A total of 1255 stocks saw an increase in average transaction volume, with 15 stocks experiencing a growth of over 50%. Conversely, 3315 stocks reported a decrease in transaction volume. Notable stocks with significant increases include Wenke Co., Ltd., Shanhe Pharmaceutical, and Sanjia Technology [1] Active Stocks by Transaction Volume - The stocks with the highest increase in average transaction volume include: - Wenke Co., Ltd. (10.09% increase, 3841 shares, 241.99% increase) - Shanhe Pharmaceutical (20.01% increase, 1613 shares, 125.77% increase) - Sanjia Technology (9.99% increase, 983 shares, 112.27% increase) [2] Active Stocks by Transaction Count - The stocks with the highest increase in transaction count include: - Sanwei Communication (481,875 transactions, 10799.68% increase) - ST Keli Da (3,235 transactions, 3797.59% increase) - Sanjiang Shopping (128,956 transactions, 3237.37% increase) [3] Stocks with Significant Increases in Both Volume and Count - Shanhe Pharmaceutical stands out with a 20.01% increase in price, an average transaction volume of 1613 shares (125.77% increase), and a transaction count of 25,673 (98.97% increase) [4] - Other notable stocks include: - Jiangshan Co., Ltd. (9.99% increase, 795 shares, 97.34% increase, 38,300 transactions, 61.17% increase) - Dibei Electric (10.01% increase, 921 shares, 61.43% increase, 18,200 transactions, 244.11% increase) [5]

Core Viewpoint - The stock price of Xinlicheng has experienced an abnormal fluctuation, with a cumulative increase of over 20% in the closing price over two consecutive trading days, prompting a self-examination by the company which found no violations of information disclosure regulations [1] Company Summary - Xinlicheng is primarily engaged in the production and sales of pharmaceuticals and hospital management [1] - For the period from January to September 2025, Xinlicheng reported a revenue of 2.256 billion yuan, representing a year-on-year decline of 23.40% (adjusted) [1] - The company incurred a net loss of 38 million yuan, with the loss expanding by 167.83% year-on-year (adjusted) [1] Industry Summary - On January 13, the Ministry of Civil Affairs and seven other departments issued measures to cultivate the operating entities in the elderly care service sector and promote the development of the silver economy, proposing 14 specific measures across five areas [1]

Group 1 - The core point of the article highlights that the trading volume of Xinlilun reached 1.041 billion yuan, marking a new high since December 27, 2024 [2] - The latest stock price increased by 2.91%, with a turnover rate of 10.99% [2] - The trading volume for the previous trading day was 201 million yuan [2]

Core Viewpoint - The company, Xinliming, announced that its stock price experienced an abnormal fluctuation, with a cumulative closing price increase of over 20% over two consecutive trading days (January 13 and January 14, 2026) [1] Group 1 - The company confirmed that there are no corrections or supplements needed for previously disclosed information [1] - No significant undisclosed major information has been reported in public media that could have impacted the company's stock price [1] - The company's operational activities are normal, and there have been no significant changes in its disclosed business conditions or external operating environment [1]

新里程健康科技集团股份有限公司 证券简称：新里程 证券代码：002219 公告编号：2026-002 新里程健康科技集团股份有限公司 关于股票交易异常波动公告 本公司及董事会全体成员保证公告内容真实、准确和完整，没有虚假记载、 误导性陈述或者重大遗漏。 一、股票交易异常波动情况的说明 新里程健康科技集团股份有限公司（以下简称"新里程"或"公司"）（证券 简称：新里程，证券代码：002219）股票交易价格连续2个交易日（2026年1月13 日和2026年1月14日）收盘价格涨幅偏离值累计超过20%，根据《深圳证券交易所 交易规则》的有关规定，属于股票交易异常波动情况。 二、公司关注、核实情况说明 针对公司股票交易异常波动，公司对有关事项进行了核查，有关情况说明如 下： 3、公司已披露的经营情况、内外部经营环境未发生重大变化，公司生产经 营活动正常。 4、经公司自查，并向控股股东发函询证，截至本公告披露日，除公司已披 露的重大事项外，公司及控股股东不存在其他应披露而未披露的重大信息。 5、经核查，控股股东在股票交易波动期间不存在买卖公司股票的情形。 三、是否存在应披露而未披露信息的说明 除已披露的事项外目前没有任 ...

新里程公告称，公司股票交易价格连续2个交易日（2026年1月13日和14日）收盘价格涨幅偏离值累计超 20%，属异常波动。经核查，公司前期披露信息无需更正、补充，经营环境未变，生产正常，公司及控 股股东无应披露未披露重大信息，控股股东在波动期间无买卖公司股票情形。公司预计4月3日披露2025 年年报，提醒投资者关注指定媒体信息，注意风险。 ...